中国经济网北京10月9日讯 芯碁微装(688630.SH)9月30日晚间发布控股股东、实际控制人减持股份计划 公告。 截至公告披露日，芯碁微装控股股东、实际控制人、董事长程卓直接持有公司股份36,787,490股，占公 司总股本的27.92%。上述股份均来源于公司首次公开发行前取得的股份，并已上市流通。 2021年4月1日，芯碁微装在上交所科创板上市，发行数量为3020.24万股，发行价格为15.23元/股，保荐 机构为海通证券股份有限公司（现名"国泰海通证券股份有限公司"），保荐代表人为于军杰、林剑辉。 芯碁微装募集资金总额为4.60亿元，扣除发行费用后，募集资金净额为4.16亿元。芯碁微装最终募集资 金净额比原计划少5708.17万元。芯碁微装2021年3月29日披露的招股说明书显示，公司拟募集资金4.73 亿元，其中，2.08亿元用于高端PCB激光直接成像（LDI）设备升级迭代项目，9380.00万元用于晶圆级 封装（WLP）直写光刻设备产业化项目，1.08亿元用于平板显示（FPD）光刻设备研发项目，6355.00万 元用于微纳制造技术研发中心建设项目。 芯碁微装的上市发行费用合计为4362.50万元， ...

神通科技于2025年9月29日收到宁波必恒创业投资合伙企业（有限合伙）（以下简称"必恒投资"） 的通知，必恒投资于2025年9月15日至2025年9月29日通过集中竞价和大宗交易方式减持公司股份 6,656,358股。 此外，自2025年9月12日至2025年9月26日，公司2023年限制性股票与股票期权激励计划股票期 权累计行权并完成股份过户登记300股，导致公司总股本由432,270,117股变动为432,270,417股。 上述原因导致一致行动人合计持有公司股份比例由73.77%减少至72.23%，权益变动触及1%刻 度。 以神通科2025年9月15日至2025年9月29日加权均价价17.91元计算，必恒投资套现金额为 11921.54万元。 根据神通科技披露的2024年年度报告，该公司控股股东为宁波神通投资有限公司，实际控制人为 方立锋和陈小燕夫妇。必恒投资为方立锋之妹方芳控制的企业。 神通科技于2021年1月20日在上交所主板上市，发行数量为8000万股，发行价格为5.89元/股，保 荐机构为东方投行，保荐代表人为吕绍昱、崔洪军。 中国经济网北京9月30日讯 神通科技（605228.SH）昨晚发布关 ...

| 股东名称 | 減持方式 | 减持期间 | 减持均价 (元/股) | 减持股数 (股) | 减持比例 | | --- | --- | --- | --- | --- | --- | | 李虎 | 竞价交易 | 2025年9月 18 日 | 131. 89 | 934, 800 | 0. 41201% | | | 大宗交易 | 2025年9月 15 日 | 101. 00 | 2, 014, 900 | 0. 88807% | 中国经济网北京9月23日讯德明利（001309）(001309.SZ)昨晚发布关于公司控股股东、实际控制人减持 计划实施完毕的公告。近日，公司收到控股股东、实际控制人李虎、田华出具的《股份减持进展告知 函》《简式权益变动报告书》，获悉李虎、田华本次减持计划已实施完毕。 德明利首次公开发行股票募集资金总额为人民币53080.00万元，募集资金净额为45589.24万元。德明利 于2022年6月20日披露的招股说明书显示，该公司原拟募集资金45,589.24万元，分别用于"3DNAND闪 存主控芯片及移动存储模组解决方案技术改造及升级项目""SSD主控芯片技术开发、应用及产业化项 目""深 ...

Core Points - Yirui Technology (688301) closed at 114.81 yuan on September 5, 2025, down 4.88% from last week's 120.7 yuan [1] - The company's current market capitalization is 22.987 billion yuan, ranking 9th out of 126 in the medical device sector and 805th out of 5152 in the A-share market [1] Trading Information - On September 5, Yirui Technology recorded a large transaction of 222 million yuan [3] Company Announcements - Yirui Technology plans to issue A-shares to specific investors, raising no more than 1.1736 billion yuan for the construction of X-ray vacuum devices and comprehensive solutions [1] - The number of shares to be issued will not exceed 15% of the total share capital before issuance, amounting to no more than 30,032,755 shares [1] - The issuance has been approved by the board of directors, the shareholders' meeting, and has received regulatory approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [1]

Core Viewpoint - The financial performance of Shijin Technology (301030.SZ) has significantly declined in 2024 and the first half of 2025, with substantial losses reported in both revenue and net profit [1][2]. Financial Performance Summary - In the first half of 2025, the company achieved operating revenue of 1.057 billion yuan, a year-on-year decrease of 48.24%, and a net profit attributable to shareholders of -120 million yuan, compared to 129 million yuan in the same period last year [1]. - For the year 2024, the company reported operating revenue of 2.054 billion yuan, down 40.34% year-on-year, with a net profit attributable to shareholders of -771 million yuan, compared to 217 million yuan in the previous year [1]. - The net profit excluding non-recurring gains and losses for 2024 was -859 million yuan, a decline from 237 million yuan in the previous year [1]. - The net cash flow from operating activities for 2024 was -547 million yuan, compared to -130 million yuan in the previous year [1]. Fundraising Activities Summary - The company raised a total of 203 million yuan through its initial public offering (IPO), with a net amount of 142 million yuan after deducting issuance costs, which was 322 million yuan less than the original plan of 464 million yuan [2]. - The total fundraising from the IPO and subsequent issuance to specific investors amounted to 623 million yuan [4]. - In 2023, the company issued 9,845,288 shares at a price of 42.66 yuan per share, raising approximately 420 million yuan, with a net amount of about 411 million yuan after expenses [3].

Core Viewpoint - China Chengda Engineering Co., Ltd. plans to reduce its stake in Huashu Co., Ltd. by up to 10 million shares, representing 0.28% of the total share capital, within a 90-day period [1] Shareholder Reduction Plan - China Chengda intends to sell no more than 10,000,000 shares, which is capped at 1% of the total shares within any consecutive 90 days [1] - As of the announcement date, China Chengda holds 180,000,000 shares, accounting for 5.01% of Huashu's total share capital [1] Shareholding Structure - The top shareholders include Huai Bei Mining Group with 1,740,036,832 shares (48.41%), Anhui Wantou Industrial Investment Co., Ltd. with 359,473,816 shares (10.00%), and China Chengda Engineering Co., Ltd. with 180,000,000 shares (5.01%) [2] - Huashu Co., Ltd. was listed on the Shanghai Stock Exchange on November 26, 2021, with an initial public offering of 386 million shares at a price of 3.94 yuan per share [2] Fundraising and Financials - Huashu raised a total of 1.521 billion yuan through its initial public offering, with a net amount of 1.402 billion yuan after deducting issuance costs [3] - The company plans to use the raised funds for various projects, including energy efficiency upgrades and production expansions [3] - The total fundraising from two rounds amounts to 1.721 billion yuan [4]

Core Insights - Chipsea Technology (688595.SH) reported a revenue of 374 million yuan for the first half of 2024, marking a year-on-year increase of 6.80% [1][2] - The net profit attributable to shareholders was -38.83 million yuan, an improvement from -56.82 million yuan in the same period last year [1][2] - The company experienced a negative cash flow from operating activities of -24.19 million yuan, compared to -80.46 million yuan in the previous year [2] Financial Performance - Revenue for the first half of 2024: 374 million yuan, up 6.80% from 350 million yuan in the previous year [2] - Total profit for the period: -46.75 million yuan, an improvement from -62.99 million yuan year-on-year [2] - Net profit attributable to shareholders: -38.83 million yuan, improved from -56.82 million yuan [2] - Net profit excluding non-recurring gains and losses: -39.63 million yuan, improved from -60.84 million yuan [2] - Cash flow from operating activities: -24.19 million yuan, improved from -80.46 million yuan [2] Historical Performance - In 2022 and 2023, the net profit attributable to shareholders was 0.03 million yuan and -14.3 million yuan, respectively [3] - The net profit excluding non-recurring gains and losses for the same years was -4 million yuan and -15.7 million yuan [3] Capital Raising and Stock Issuance - Chipsea Technology raised a total of 571 million yuan through its initial public offering, with a net amount of 494 million yuan after expenses [3] - The company issued convertible bonds in 2022, raising 410 million yuan [4] - The total fundraising from both IPO and bond issuance amounted to 981 million yuan [4] Future Plans - The company is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries [5]

Group 1 - The stock of Wankai New Materials (301216.SZ) closed at 15.94 yuan, with a decline of 3.57%, currently in a state of breaking issue [1] - Wankai New Materials was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on March 29, 2022, with an initial public offering (IPO) of 85.85 million shares at a price of 35.68 yuan per share [1] - The total amount raised from the IPO was 3.063 billion yuan, with a net amount of 2.915 billion yuan, exceeding the planned amount by 1.411 billion yuan [1] Group 2 - The company plans to use the raised funds for a 1.2 million tons per year food-grade PET polymer new materials project (Phase II), multifunctional green and environmentally friendly polymer new materials project, and to supplement working capital [1] - The total issuance costs for the IPO were 148 million yuan, including underwriting fees of 123 million yuan [1] - On May 31, 2023, Wankai New Materials announced a dividend plan, distributing 3 yuan (pre-tax) for every 10 shares and a bonus issue of 5 shares [1] Group 3 - On September 4, 2024, Wankai New Materials disclosed a convertible bond issuance announcement, aiming to raise up to 2.7 billion yuan (including issuance costs) [2] - The net amount raised from the convertible bond issuance will be used for a 1.2 million tons per year MEG project and to supplement working capital [2] - The total amount raised from both the IPO and the convertible bond issuance is calculated to be 5.763 billion yuan [2]

Group 1 - The controlling shareholder, Shanghai Bujin Information Consulting Co., Ltd., plans to reduce its holdings in Buke Co., Ltd. by up to 2,724,966 shares, accounting for no more than 3% of the total share capital [1] - The reduction will occur through centralized bidding and block trading, with a maximum of 908,322 shares (1% of total share capital) through centralized bidding and 1,816,644 shares (2% of total share capital) through block trading [1] - As of the announcement date, Shanghai Bujin holds 36,979,753 shares, representing 40.71% of the total share capital, which will be released from restrictions on November 13, 2023 [1] Group 2 - The reduction plan is driven by Shanghai Bujin's own funding needs and will not lead to changes in the controlling shareholder or actual controller of Buke Co., Ltd., nor will it significantly impact the company's stable operations [2] - Buke Co., Ltd. was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 12, 2020, with an issuance of 21 million shares at a price of 20.34 yuan per share, raising a total of 427 million yuan [2] - The net fundraising amount after deducting issuance costs was 381 million yuan, which was 111 million yuan more than originally planned [2] Group 3 - Buke Co., Ltd. has received approval from the China Securities Regulatory Commission for a specific issuance of A-shares, raising approximately 465 million yuan after deducting issuance costs [3] - The total amount raised from the two fundraising activities is 892 million yuan [4] - The company's revenue and net profit figures for 2022 to 2024 are as follows: revenue of 539 million yuan, 506 million yuan, and 547 million yuan; net profit attributable to shareholders of 91 million yuan, 60 million yuan, and 49 million yuan [4]

Group 1 - Gannee Pharmaceutical announced a share reduction plan involving major shareholders and executives [1][2] - Beijing Xute Hongda Technology Co., Ltd. and its concerted actor Gan Zhongru hold a combined 241,116,992 shares, representing 40.11% of the total share capital [1][2] - The share reduction plan includes a maximum of 3,399,518 shares to be sold by Xute Hongda, accounting for 0.57% of the total share capital [2] Group 2 - Gannee Pharmaceutical was listed on the Shanghai Stock Exchange on June 29, 2020, with an initial public offering (IPO) of 40.2 million shares at a price of 63.32 yuan per share [3] - The total funds raised from the IPO amounted to 2.545 billion yuan, with a net amount of 2.441 billion yuan after expenses [3] - The funds from the IPO were allocated for various projects, including marketing network construction and product registration in the U.S. [3] Group 3 - In 2023, Gannee Pharmaceutical raised funds through a targeted issuance of shares, issuing 28,508,550 shares at a price of 27.12 yuan each [4] - The total amount raised from this issuance was approximately 773.15 million yuan, with a net amount of about 759.73 million yuan after expenses [4] - The combined total funds raised from both the IPO and the targeted issuance is approximately 3.318 billion yuan [4]